Balance Sheet for Edesa Biotech Inc. (EDSA)

$ 3.60   -0.0299 (-0.82%) Volume: 30.35k 3:59 PM EST Feb 21, 2020
Statement: View:
Assets [+] in Thousands of Dollars
09/2018 09/2017 09/2016 09/2015 09/2014
Cash and Equivalents 4,226 4,571 7,417 3,956 8,768
Restrictable Cash - - - - -
Marketable Securities 6,078 1,994 3,989 5,015 5,450
Accounts Receivable 41 1 86 158 44
Loans Receivable - - - - 60
Other Receivables - - - - 195
Receivables 41 1 86 158 44
Inventories, Raw Materials 47 22 39 43 10
Inventories, Work in Progress 83 - 43 137 24
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 94 46 167 378 -
Inventories, Other 224 68 249 557 35
Inventories, Adjustments & Allowances - - - - -
Inventories 224 68 249 557 35
Prepaid Expenses 87 124 359 181 126
Current Deferred Income Taxes - - - - -
Other Current Assets - - 694 - -
Total Current Assets 10,656 6,758 12,100 9,867 14,423
Land and Improvements - - - - -
Buildings and Improvement 347 337 282 124 61
Machinery, Furniture and Equipment 266 258 213 152 151
Construction in Progress 426 145 33 32 -
Fixed Assets, Other 1,169 1,109 1,021 839 695
Fixed Assets, Total 2,209 1,849 1,549 1,147 907
Gross Fixed Assets 2,209 1,849 1,549 1,147 907
Accumulated Depreciation (1,147) (969) (793) (643) (518)
Net Fixed Assets 1,062 880 756 503 388
Intangibles - - - - 307
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets - - 838 - -
Total Non-Current Assets 1,124 962 838 519 404
Total Assets 11,780 7,720 12,938 10,386 14,828
Liabilities [+] in Thousands of Dollars
09/2018 09/2017 09/2016 09/2015 09/2014
Accounts Payable 493 321 624 657 585
Short Term Debt - - - - -
Notes Payable - - - - -
Accrued Expenses - - - - -
Accrued Liabilities - - - - -
Deferred Revenues - - - 173 87
Current Deferred Income Taxes - - - - -
Other Current Liabilities - - - 1,551 0
Total Current Liabilities 493 321 624 2,381 672
Long Term Debt - - - - -
Deferred Income Tax - - - - -
Other Non-Current Liabilities - - - - 3,691
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities - - - - 3,691
Total Liabilities 493 321 624 2,381 4,363
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 11,287 7,399 12,314 8,005 10,465
Common Par 56,653 - - - -
Additional Paid in Capital 56,653 48,352 47,281 38,114 37,884
Cumulative Translation Adjustments - - - - -
Retained Earnings (50,431) (45,392) (40,361) (35,335) (32,492)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization 11,287 7,399 12,314 8,005 10,465
Total Equity 11,287 7,399 12,314 8,005 10,465
Total Liabilities & Shareholder's Equity 11,780 7,720 12,938 10,386 14,828
Cash Flow (5,039) (5,031) (5,026) (2,843) (7,312)
Working Capital 10,163 6,438 11,476 7,486 13,751
Free Cash Flow (4,998) (5,002) (4,908) (4,687) (310)
Invested Capital 11,287 7,399 12,314 8,005 10,465
Shares Outstanding - Common Class Only 888 250 241 190 186
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 888 250 241 190 552
Total Common Shares Outstanding 888 250 241 190 186
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 478 244 210 189 187
Diluted Weighted Shares Outstanding 478 244 210 189 207